The Joint Corp.

NasdaqCM JYNT

The Joint Corp. Return on Capital Employed (ROCE) for the Trailing 12 Months (TTM) ending September 30, 2024: -4.79%

The Joint Corp. Return on Capital Employed (ROCE) is -4.79% for the Trailing 12 Months (TTM) ending September 30, 2024, a -762.81% change year over year. Return on capital employed assesses profitability against invested capital; higher ROCE signals efficient capital use.

The Joint Corp. Return on Capital Employed (ROCE) for the Trailing 12 Months (TTM) ending September 30, 2023 was 0.72%, a 150.62% change year over year.
The Joint Corp. Return on Capital Employed (ROCE) for the Trailing 12 Months (TTM) ending September 30, 2022 was -1.43%, a -109.29% change year over year.
The Joint Corp. Return on Capital Employed (ROCE) for the Trailing 12 Months (TTM) ending September 30, 2021 was 15.36%, a 29.07% change year over year.
The Joint Corp. Return on Capital Employed (ROCE) for the Trailing 12 Months (TTM) ending September 30, 2020 was 11.90%, a -13.45% change year over year.

Key data

Date	Return on Capital Employed (ROCE)	Interest Coverage Ratio	Debt to Equity Ratio	Return on Common Equity

NasdaqCM: JYNT

The Joint Corp.

CEO	Mr. Sanjiv Razdan
IPO Date	Nov. 11, 2014
Location	United States
Headquarters	16767 North Perimeter Drive
Employees	444
Sector	Health Care
Industries Hospitals & Clinics

Description

The Joint Corp. develops, owns, operates, supports, and manages chiropractic clinics. The company operates in two segments, Corporate Clinics and Franchise Operations. It operates through direct ownership, management arrangements, franchising, and regional developers. As of March 1, 2022, the company operated approximately 700 locations in the United States. The Joint Corp. was incorporated in 2010 and is headquartered in Scottsdale, Arizona.

Key trends

Past 5 years